cvs revision mtf

Upload: eric-nesh

Post on 13-Apr-2018

214 views

Category:

Documents


0 download

TRANSCRIPT

  • 7/25/2019 CVS Revision MTF

    1/11

    CVS REVISION

    Topics: Bacteremia, SIRS & sepsis-relateddisorders/

    Infective endocarditis.Block: Cardiovascular System C!S"

    #BBS $ear % Semester Session '%/'%(

    Lecturer-in-charge: MS

  • 7/25/2019 CVS Revision MTF

    2/11

    %. T)e follo*in+ statements are TR/0S:

    . SIRS is a systemic response *)ic) can1e due to isc)emia.

    B. SIRS criteria includes leukocytosis and

    a1normal 1ody temperature.C. Transient 1acteremia presents *it)

    )i+) fever.

    2. 3rimary #42S develops as a

    conse5uence of SIRS.. 6roup B Streptococcus is t)e most

    common cause of neonatal 1acteremia.

    T

    T

    F

    F

    T

  • 7/25/2019 CVS Revision MTF

    3/11

    . T)e follo*in+ statements are TR/0S:

    . ndoto7in activates monocytes andmacrop)a+es.

    B. Interleukinsare released 1y activated

    macrop)a+es in SIRS.C. 3atients *)o )ave under+one

    splenectomy are at increased risk ofenterococci disease.

    2. Severe sepsis is de8ned as SIRS plus1acteremia.

    . T)e 8rst indicator of septic s)ock inc)ildren is tac)ycardia.

    T

    T

    F

    F

    T

  • 7/25/2019 CVS Revision MTF

    4/11

    (. T)e follo*in+ statements are TR/0S:

    . 3rimary viremia is associated *it))i+)er viral load.

    B. T)e levels of anticoa+ulation factors

    are increased in sepsis.C. T)e release of nitric o7ide from

    endot)elial cells can lead to septics)ock.

    2. Staphylococcus epidermidiscausesdevice-associated 1acteremia.

    . Tetracycline is t)e dru+ of c)oice insepsis.

    F

    F

    T

    T

    F

  • 7/25/2019 CVS Revision MTF

    5/11

    9. T)e follo*in+ statements are TR/0S:

    . Sta+e III of SIRS is de8ned 1y t)erelease of interlukines into t)ecirculation.

    B. oradrenaline is a potent vasodialator.

    C. Secondary #42S is due to direct insultof t)e causative microor+anism.

    2. itric o7ide is a potent vasodialator.

    . Penicillium marnefei ungemia is

    commonly associated with intravenouscat)eters.

    F

    F

    F

    T

    F

  • 7/25/2019 CVS Revision MTF

    6/11

    ;. T)e follo*in+ statements are TR/0S:

    . disseminated intravascular coa+ulationis a complication of sepsis.

    B. T)e term sepsis denotes SIRS *it)

    R2S.

    C. 3atients *it) sepsis usually su

  • 7/25/2019 CVS Revision MTF

    7/11

    =. T)e follo*in+ statements are TR/0S:

    . I!2 endocarditis is due to )i+)-pressure +radients and tur1ulent >o* .

    B. m1oli formation is a complication ofinfective endocarditis.

    C. arly prost)etic valve endocarditis isdue to endot)eliali?ation of sutures.

    2. 3ulmonary valves are t)e mostcommon valves a

  • 7/25/2019 CVS Revision MTF

    8/11

    @. T)e follo*in+ statements are TR/0S:

    . Staphylococcus aureuscan infect onlynormal )eart valves.

    B. Bartonellaspecies infective endocarditisis associated *it) ne+ative 1lood

    cultures.C. Streptococcus is usually associated *it)

    acute infective endocarditis.

    2. I!2 infective endocarditis is usually

    associated *it) )i+) +rade fever.. 3rost)etic valve endocarditis 3!" is

    termed as early *)en t)e symptomsappear *it)in =' days of insertion.

    F

    T

    F

    T

    T

  • 7/25/2019 CVS Revision MTF

    9/11

    A. T)e follo*in+ statements are TR/0S:

    . Staphylococcus aureus is t)e mostcommon causative a+ent of prost)eticvalve endocarditis.

    B. C +roup is one of t)e causativea+ents of culture-ne+ativeendocarditis.

    C. Dane*ay lesions are small, tendersu1cutaneous nodules on t)e pads oft)e 8n+ers or toes t)at last for only)ours or days.

    2. Splinter )emorr)a+e is a clinicalpresentation of infective endocarditis.

    . ever of more t)an (A is a maEor 2uke

    T

    F

    T

    F

    T

  • 7/25/2019 CVS Revision MTF

    10/11

    F. T)e follo*in+ statements are TR/0S:

    . T)e treatment of prost)etic valvesinfective endocarditis is !ancomycinplus 6entamicin.

    B. T)e ve+etation o

  • 7/25/2019 CVS Revision MTF

    11/11

    %'. T)e follo*in+ statements are TR/0S:

    . T)e prop)ylactic re+ime used for

    moderate risk patients *)o *ill 1e)avin+ a +astrointestinal sur+ery isampicillin.

    B. T)e treatment re+ime of infective

    endocarditis is t)ree *eeks of )i+)dose anti1iotic.

    C. nterococci infective endocarditis isusually nosocomial ac5uired infection.

    2. I! !ancomycin *it) +entamycin areused for I!2 associated infectiveendocarditis.

    . 3rop)yla7is for oral procedures is

    directed mainly a+ainst streptococcus.

    F

    F

    T

    T

    T